Found: 30
Select item for more details and to access through your institution.
Plasma amyloid beta X‐42/X‐40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5132, doi. 10.1002/alz.13909
- By:
- Publication type:
- Article
Neue Biomarker für die Alzheimer-Krankheit in Liquor und Blut.
- Published in:
- Der Nervenarzt, 2019, v. 90, n. 9, p. 907, doi. 10.1007/s00115-019-0772-9
- By:
- Publication type:
- Article
Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01071-y
- By:
- Publication type:
- Article
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00828-1
- By:
- Publication type:
- Article
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00828-1
- By:
- Publication type:
- Article
Exosomal Aβ-Binding Proteins Identified by "In Silico" Analysis Represent Putative Blood-Derived Biomarker Candidates for Alzheimer´s Disease.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 3933, doi. 10.3390/ijms22083933
- By:
- Publication type:
- Article
Development and Technical Validation of an Immunoassay for the Detection of APP669–711 (Aβ−3–40) in Biological Samples.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6564, doi. 10.3390/ijms21186564
- By:
- Publication type:
- Article
Novel Exosome Biomarker Candidates for Alzheimer's Disease Unravelled Through Mass Spectrometry Analysis.
- Published in:
- Molecular Neurobiology, 2022, v. 59, n. 5, p. 2838, doi. 10.1007/s12035-022-02762-1
- By:
- Publication type:
- Article
Bioinformatic analysis of the SPs and NFTs proteomes unravel putative biomarker candidates for Alzheimer's disease.
- Published in:
- Proteomics, 2023, v. 23, n. 15, p. 1, doi. 10.1002/pmic.202200515
- By:
- Publication type:
- Article
Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry.
- Published in:
- Journal of Neural Transmission, 2021, v. 128, n. 6, p. 735, doi. 10.1007/s00702-021-02354-8
- By:
- Publication type:
- Article
Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease.
- Published in:
- Journal of Neural Transmission, 2019, v. 126, n. 3, p. 339, doi. 10.1007/s00702-019-01982-5
- By:
- Publication type:
- Article
Cardiovascular and metabolic comorbidities in patients with Alzheimer's disease and vascular dementia compared to a psychiatric control cohort.
- Published in:
- Psychogeriatrics, 2018, v. 18, n. 5, p. 393, doi. 10.1111/psyg.12338
- By:
- Publication type:
- Article
Dimensional clinical phenotyping using post‐mortem brain donor medical records: post‐mortem RDoC profiling is associated with Alzheimer's disease neuropathology.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 3, p. 1, doi. 10.1002/dad2.12464
- By:
- Publication type:
- Article
Higher Level of Mismatch in APOE ε 4 Carriers for Amyloid-Beta Peptide Alzheimer's Disease Biomarkers in Cerebrospinal Fluid.
- Published in:
- ASN Neuro (Sage Publications, Ltd.), 2019, v. 11, p. N.PAG, doi. 10.1177/1759091419845524
- By:
- Publication type:
- Article
Claims Data Analysis on the Dispensing of Tricyclic Antidepressants Among Patients With Dementia in Germany.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00841
- By:
- Publication type:
- Article
Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2022, v. 272, n. 5, p. 757, doi. 10.1007/s00406-021-01351-y
- By:
- Publication type:
- Article
Evolution of psychosocial burden and psychiatric symptoms in patients with psychiatric disorders during the Covid-19 pandemic.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2022, v. 272, n. 1, p. 29, doi. 10.1007/s00406-021-01268-6
- By:
- Publication type:
- Article
Correction to: Current clinical practice of electroconvulsive therapy and repetitive transcranial magnetic stimulation in psychiatry, a German sample.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Current clinical practice of electroconvulsive therapy and repetitive transcranial magnetic stimulation in psychiatry, a German sample.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2021, v. 271, n. 1, p. 181, doi. 10.1007/s00406-020-01099-x
- By:
- Publication type:
- Article
Prevalence of affective disorders and dementia in inflammatory polyarthropathies.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 2, p. 247, doi. 10.1007/s00406-019-01015-y
- By:
- Publication type:
- Article
Identification of risk factors for delirium, cognitive decline, and dementia after cardiac surgery (FINDERI-find delirium risk factors): a study protocol of a prospective observational study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Detection and quantification of Aβ−3–40 (APP669‐711) in cerebrospinal fluid.
- Published in:
- Journal of Neurochemistry, 2022, v. 160, n. 5, p. 578, doi. 10.1111/jnc.15571
- By:
- Publication type:
- Article
A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0448-x
- By:
- Publication type:
- Article
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0418-3
- By:
- Publication type:
- Article
Multiplex immunoassay measurement of amyloid-β<sub>42</sub> to amyloid-β<sub>40</sub> ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia not due to Alzheimer’s disease.
- Published in:
- Experimental Brain Research, 2018, v. 236, n. 5, p. 1241, doi. 10.1007/s00221-018-5210-x
- By:
- Publication type:
- Article
Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 1573, doi. 10.1002/alz.13557
- By:
- Publication type:
- Article
Using Natural Language Processing to identify psychiatric symptoms related to Alzheimer's disease: a novel tool to enhance molecular brain research in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075743
- By:
- Publication type:
- Article
Using Natural Language Processing to identify psychiatric symptoms related to Alzheimer's disease: a novel tool to enhance molecular brain research in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 1, doi. 10.1002/alz.082115
- By:
- Publication type:
- Article
Using Natural Language Processing to identify psychiatric symptoms related to Alzheimer's disease: a novel tool to enhance molecular brain research in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075743
- By:
- Publication type:
- Article
Prognostic value of plasma Amyloid‐β 42/40 ratio in early and pre‐clinical AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.063242
- By:
- Publication type:
- Article